Alain Saint-Pierre is a Doctor of Pharmacology and a member of the National Academy of Pharmacy. The author states that he has no interest in the topic.
After a long and careful process aimed especially at evaluating the benefit-risk ratio, the marketing authorization (AMM) of the health product is a guarantee of efficacy and safety for the prescriber. It is always given for one (or several) clinical situations, and the fact that the drug has a marketing authorization does not allow its use in pathologies that this marketing authorization does not mean. Some clinical situations may require the use of drugs that do not have a marketing authorization for the intended indications, but even in these situations the freedom of prescription is not complete; more recently, diversion procedures have been implemented to replace previously considered complex procedures.
• Early Access Authorization Procedure (AAP)
AAP is designed to enable…
Source: Le Figaro
I am John Sinkler, a professional writer and journalist for Buna Times. I specialize in writing about entertainment-related topics and have been doing so for several years now. My work has been featured on multiple platforms and I’m proud to say that it’s gained recognition from many people in the industry. Aside from working at Buna Times, I also write freelance articles for other publications.